(1.26%) 5 127.79 points
(1.18%) 38 676 points
(1.99%) 16 156 points
(-1.22%) $77.99
(5.65%) $2.15
(0.02%) $2 310.10
(-0.16%) $26.79
(0.37%) $966.20
(-0.35%) $0.929
(-1.07%) $10.87
(-0.11%) $0.797
(0.36%) $91.45
2 days till quarter result
(amc 2024-05-06)
Expected move: +/- 3.30%
-0.27% $ 528.86
Live Chart Being Loaded With Signals
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS)...
Stats | |
---|---|
Объем за сегодня | 856 628 |
Средний объем | 702 582 |
Рыночная капитализация | 69.50B |
EPS | $0 ( 2024-02-07 ) |
Дата следующего отчета о доходах | ( $0 ) 2024-05-06 |
Last Dividend | $0.620 ( 2023-12-01 ) |
Next Dividend | $0 ( N/A ) |
P/E | 23.92 |
ATR14 | $0.323 (0.06%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Tyler Brian S. | Buy | 3 473 | Common Stock |
2024-03-15 | Tyler Brian S. | Sell | 3 473 | Common Stock |
2024-03-15 | Tyler Brian S. | Sell | 3 473 | Employee Stock Option (Right-to-buy) |
2024-03-01 | Rutledge Napoleon B Jr | Buy | 613 | Common Stock |
2024-03-01 | Rutledge Napoleon B Jr | Sell | 183 | Common Stock |
INSIDER POWER |
---|
-47.92 |
Last 99 transactions |
Buy: 81 873 | Sell: 255 959 |
Объем Корреляция
Mckesson Corp Корреляция
10 Самые положительные корреляции |
---|
10 Самые отрицательные корреляции |
---|
Вы знали?
Корреляция - это статистический показатель, описывающий связь между двумя переменными. Он изменяется от -1 до 1, где -1 указывает на идеальную отрицательную корреляцию (при увеличении одной переменной другая уменьшается), 1 указывает на идеальную положительную корреляцию (при увеличении одной переменной другая увеличивается), а 0 указывает на отсутствие корреляции (между переменными нет связи).
Корреляцию можно использовать для анализа связи между любыми двумя переменными, не только акциями. Она широко используется в таких областях, как финансы, экономика, психология и т. д.
Mckesson Corp Корреляция - Валюта/Сырье
Mckesson Corp Финансовые показатели
Annual | 2023 |
Выручка: | $276.71B |
Валовая прибыль: | $12.36B (4.47 %) |
EPS: | $25.23 |
FY | 2023 |
Выручка: | $276.71B |
Валовая прибыль: | $12.36B (4.47 %) |
EPS: | $25.23 |
FY | 2022 |
Выручка: | $263.97B |
Валовая прибыль: | $13.13B (4.97 %) |
EPS: | $7.31 |
FY | 2021 |
Выручка: | $238.23B |
Валовая прибыль: | $12.15B (5.10 %) |
EPS: | $-28.26 |
Financial Reports:
No articles found.
Mckesson Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.540 (N/A) |
$0.540 (N/A) |
$0.540 (N/A) |
$0.540 (N/A) |
$0.620 (N/A) |
$1.240 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.125 | 1994-12-09 |
Last Dividend | $0.620 | 2023-12-01 |
Next Dividend | $0 | N/A |
Payout Date | 2024-01-02 | |
Next Payout Date | N/A | |
# dividends | 118 | -- |
Total Paid Out | $24.02 | -- |
Avg. Dividend % Per Year | 0.59% | -- |
Score | 3.68 | -- |
Div. Sustainability Score | 4.51 | |
Div.Growth Potential Score | 1.805 | |
Div. Directional Score | 3.16 | -- |
Year | Amount | Yield |
---|---|---|
1994 | $0.125 | 0.76% |
1995 | $0.375 | 2.27% |
1996 | $0.500 | 2.02% |
1997 | $0.500 | 1.79% |
1998 | $0.500 | 0.94% |
1999 | $0.240 | 0.31% |
2000 | $0.240 | 1.02% |
2001 | $0.240 | 0.68% |
2002 | $0.240 | 0.64% |
2003 | $0.240 | 0.86% |
2004 | $0.240 | 0.78% |
2005 | $0.240 | 0.77% |
2006 | $0.240 | 0.45% |
2007 | $0.240 | 0.47% |
2008 | $0.420 | 0.66% |
2009 | $0.480 | 1.23% |
2010 | $0.660 | 1.04% |
2011 | $0.780 | 1.10% |
2012 | $0.800 | 1.01% |
2013 | $0.900 | 0.92% |
2014 | $0.960 | 0.60% |
2015 | $1.040 | 0.50% |
2016 | $1.120 | 0.58% |
2017 | $1.240 | 0.84% |
2018 | $1.460 | 0.92% |
2019 | $1.600 | 1.42% |
2020 | $1.660 | 1.20% |
2021 | $1.780 | 1.02% |
2022 | $2.02 | 0.81% |
2023 | $2.94 | 0.79% |
2024 | $0 | 0.00% |
The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
ORC | Dividend Royal | 2023-11-29 | Monthly | 12 | 9.23% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
NCZ | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.79% | 8.50 |
VGI | Dividend Royal | 2024-02-09 | Monthly | 13 | 7.36% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
ZTR | Dividend Royal | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend King | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.00994 | 1.500 | 9.80 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0451 | 1.200 | 8.50 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | -1.634 | 1.500 | -10.00 | -10.00 | [0.1 - 1] |
payoutRatioTTM | 0.103 | -1.000 | 8.97 | -8.97 | [0 - 1] |
currentRatioTTM | 0.922 | 0.800 | -0.389 | -0.311 | [1 - 3] |
quickRatioTTM | 0.485 | 0.800 | -1.854 | -1.483 | [0.8 - 2.5] |
cashRatioTTM | 0.0384 | 1.500 | -0.898 | -1.347 | [0.2 - 2] |
debtRatioTTM | 0.114 | -1.500 | 8.09 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 14.63 | 1.000 | 5.69 | 5.69 | [3 - 30] |
operatingCashFlowPerShareTTM | 26.35 | 2.00 | 1.215 | 2.43 | [0 - 30] |
freeCashFlowPerShareTTM | 21.83 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | -3.71 | -1.500 | -10.00 | 10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.0408 | 1.000 | -2.65 | -2.65 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0122 | 1.000 | -1.756 | -1.756 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.459 | 1.000 | 8.56 | 8.56 | [0.2 - 2] |
assetTurnoverTTM | 4.53 | 0.800 | 10.00 | 8.00 | [0.5 - 2] |
Total Score | 4.51 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 23.37 | 1.000 | 7.74 | 0 | [1 - 100] |
returnOnEquityTTM | -1.634 | 2.50 | -10.00 | -10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 21.83 | 2.00 | 2.72 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.454 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 26.35 | 2.00 | 1.215 | 2.43 | [0 - 30] |
payoutRatioTTM | 0.103 | 1.500 | 8.97 | -8.97 | [0 - 1] |
pegRatioTTM | -0.0363 | 1.500 | -3.58 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0116 | 1.000 | -2.21 | 0 | [0.1 - 0.5] |
Total Score | 1.805 |
Mckesson Corp
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment serves biopharma and life sciences partners and patients to address medication challenges for patients throughout their journeys; connects pharmacies, providers, payers, and biopharma companies to deliver innovative access and adherence solutions; and provides third-party logistics and wholesale distribution support solutions. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
О Торговые сигналы
Данные торговые сигналы, представленные на этой странице, помогают определить, когда следует ПОКУПАТЬ или ПРОДАВАТЬ NA. Сигналы имеют задержку более 1 минуты. Пожалуйста, примите во внимание, что существует вероятность ошибки или неточностей в силу различных микро и макро факторов влияющих на фондовые рынки.
Данные тор“о”ые сигна“ы не являются определен“ыми, и getagraph.com не несет ответственности за какие-либо действия, предпринятые в от“ошении этих сигналов, как описано в Terms of Use. Сигналы основаны на широком спектре индикаторов технического анализа